Influence of loxP insertion upstream of the cis-acting packaging domain on adenovirus packaging efficiency

Microbiology and Immunology

Volumn 56, Issue 7, 2012, Pages 447-455

  Kanegae, Yumi ^a   Ishimura, Masakazu ^a,b   Kondo, Saki ^a   Saito, Izumu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KAKEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Helper dependent adenovirus vector; loxP; Site specific recombinase; Viral packaging

Indexed keywords

ADENOVIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; DNA PACKAGING; GENE; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; LOXP GENE; MARKER GENE; NONHUMAN; VIRUS GENOME;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; BASE SEQUENCE; CELL LINE; GENETIC VECTORS; HELPER VIRUSES; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; VIRUS ASSEMBLY; VIRUS INTEGRATION;

ADENOVIRIDAE;

EID: 84862902239     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00454.x     Document Type: Article

References (38)

1. Ali M., Lemoine N.R., Ring C.J. (1994) The use of DNA viruses as vectors for gene therapy. Gene Ther 1: 367-84.
2. Tsukui T., Kanegae Y., Saito I., Toyoda Y. (1996) Transgenesis by adenovirus-mediated gene transfer into mouse zona-free eggs. Nat Biotechnol 14: 982-5.
3. Wilson J.M. (1996) Adenoviruses as gene-delivery vehicles. N Engl J Med 334: 1185-7.
4. Shibata H., Toyama K., Shioya H., Ito M., Hirota M., Hasegawa S., Matsumoto H., Takano H., Akiyama T., Toyoshima K., Kanamaru R., Kanegae Y., Saito I., Nakamura Y., Shiba K., Noda T. (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278: 120-3.
5. Kafri T., Morgan D., Krahl T., Sarvetnick N., Sherman L., Verma I. (1998) Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci U S A 95: 11377-82.
6. O'Neal W.K., Zhou H., Morral N., Aguilar-Cordova E., Pestaner J., Langston C., Mull B., Wang Y., Beaudet A.L., Lee B. (1998) Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery. Hum Gene Ther 9: 1587-98.
7. Palmer D.J., Ng P. (2005) Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther 16: 1-16.
8. Nakai M., Komiya K., Murata M., Kimura T., Kanaoka M., Kanegae Y., Saito I. (2007) Expression of pIX gene induced by transgene promoter: possible cause of host immune response in first-generation adenoviral vectors. Hum Gene Ther 18: 925-36.
9. Parks R.J., Chen L., Anton M., Sankar U., Rudnicki M.A., Graham F.L. (1996) A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 93: 13565-70.
10. Kochanek S. (1999) High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum Gene Ther 10: 2451-9.
11. Sternberg N., Hamilton D. (1981) Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150: 467-86.
12. Sauer B., Henderson N. (1989) Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 17: 147-61.
13. Broach J.R., Guarascio V.R., Jayaram M. (1982) Recombination within the yeast plasmid 2mu circle is site-specific. Cell 29: 227-34.
14. Buchholz F., Angrand P.O., Stewart A.F. (1998) Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat Biotechnol 16: 657-62.
15. Nakano M., Odaka K., Ishimura M., Kondo S., Tachikawa N., Chiba J., Kanegae Y., Saito I. (2001) Efficient gene activation in cultured mammalian cells mediated by FLP recombinase-expressing recombinant adenovirus. Nucleic Acids Res 29: E40.
16. Ng P., Beauchamp C., Evelegh C., Parks R., Graham F.L. (2001) Development of a FLP/frt system for generating helper-dependent adenoviral vectors. Mol Ther 3: 809-15.
17. Umana P., Gerdes C.A., Stone D., Davis J.R., Ward D., Castro M.G., Lowenstein P.R. (2001) Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nat Biotechnol 19: 582-5.
18. Hearing P., Samulski R.J., Wishart W.L., Shenk T. (1987) Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J Virol 61: 2555-8.
19. Schmid S.I., Hearing P. (1997) Bipartite structure and functional independence of adenovirus type 5 packaging elements. J Virol 71: 3375-84.
20. Schmid S.I., Hearing P. (1998) Cellular components interact with adenovirus type 5 minimal DNA packaging domains. J Virol 72: 6339-47.
21. Ostapchuk P., Yang J., Auffarth E., Hearing P. (2005) Functional interaction of the adenovirus IVa2 protein with adenovirus type 5 packaging sequences. J Virol 79: 2831-8.
22. Zhang W., Imperiale M.J. (2003) Requirement of the adenovirus IVa2 protein for virus assembly. J Virol 77: 3586-94.
23. Hearing P., Shenk T. (1986) The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis. Cell 45: 229-36.
24. Maeda Y., Kimura E., Uchida Y., Nishida Y., Yamashita S., Arima T., Uchino M. (2003) Cre/loxP-mediated adenovirus type 5 packaging signal excision demonstrates that core element VI is sufficient for virus packaging. Virology 309: 330-8.
25. Sato M., Suzuki S., Kubo S., Mitani K. (2002) Replication and packaging of helper-dependent adenoviral vectors. Gene Ther 9: 472-6.
26. Zhou H.S., Zhao T., Rao X.M., Beaudet A.L. (2002) Production of helper-dependent adenovirus vector relies on helper virus structure and complementing. J Gene Med 4: 498-509.
27. Miyake S., Makimura M., Kanegae Y., Harada S., Sato Y., Takamori K., Tokuda C., Saito I. (1996) Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A 93: 1320-4.
28. Kim D.W., Uetsuki T., Kaziro Y., Yamaguchi N., Sugano S. (1990) Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 91: 217-23.
29. Ginsberg H.S. (1984) The Adenoviruses. Plenum Press, New York.
30. Kanegae Y., Makimura M., Saito I. (1994) A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47: 157-66.
31. Saito I., Oya Y., Yamamoto K., Yuasa T., Shimojo H. (1985) Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J Virol 54: 711-9.
32. Sato Y., Tanaka K., Lee G., Kanegae Y., Sakai Y., Kaneko S., Nakabayashi H., Tamaoki T., Saito I. (1998) Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector. Biochem Biophys Res Commun 244: 455-62.
33. Ng P., Evelegh C., Cummings D., Graham F.L. (2002) Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system. J Virol 76: 4181-9.
34. Ng P., Parks R.J., Graham F.L. (2002) Preparation of helper-dependent adenoviral vectors. Methods Mol Med 69: 371-88.
35. Loonstra A., Vooijs M., Beverloo H.B., Allak B.A., van Drunen E., Kanaar R., Berns A., Jonkers J. (2001) Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci U S A 98: 9209-14.
36. Pfeifer A., Brandon E.P., Kootstra N., Gage F.H., Verma I.M. (2001) Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci U S A 98: 11450-5.
37. Silver D.P., Livingston D.M. (2001) Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8: 233-43.
38. Baba Y., Nakano M., Yamada Y., Saito I., Kanegae Y. (2005) Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol Immunol 49: 559-70.